Examples of using Open-label in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
In two open-label studies BeneFIX was found to be safely administered at 100 IU/kg once-weekly.
In the single-arm, open-label trial in SAA, patients had bone
A multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab
Preliminary results from a supportive study(Study ELT116826), an ongoing non-randomised, phase II, single-arm, open-label study in refractory SAA subjects,
In open-label studies, doses up to 15,000 U were given to patients at intervals of not less than 12 weeks.
In the open-label study there was no difference in overall survival between patients treated with recombinant human erythropoietin and controls.
A multicenter, randomized, open-label study was conducted in 1052 chemotherapy-naive patients with Stage IIIb/IV non-small cell lung cancer.
Revestive was studied in a 12-week, open-label, clinical study in 42 paediatric subjects aged 1 year through 14 years with SBS who were dependent on parenteral nutrition.
However, patients completing STRIDE-2 were eligible to enrol in open-label studies STRIDE-2X and STRIDE-3.
controlled, open-label study in which 173 subjects with previously treated CLL received idelalisib+ ofatumumab.
A randomised, open-label, multicentre study was conducted in 2,098 anaemic women with metastatic breast cancer,
This is supported by 96 week data from an open-label, randomized and active- controlled study FLAMINGO(ING114915)
The effect of multiple doses of Arzerra on the QTc interval was evaluated in a pooled analysis of three open-label studies in patients with CLL N=85.
The efficacy and safety of degarelix was evaluated in an open-label, multi-centre, randomised,
Phase III Clinical Trials Two randomised, open-label studies were conducted to evaluate the efficacy of dasatinib administered once daily compared with dasatinib administered twice daily.
Multiple course therapy Following completion of the 24-week double blind comparative study period, patients were permitted to enroll into an open-label long term follow up study.
The efficacy and safety of Eurartesim have been assessed in two large randomised, open-label clinical trials.
The safety and efficacy of Oncaspar was evaluated in an open-label, multicenter, randomized, active-controlled study Study 1.
CRAD001C2485: This was a prospective, open-label, single-arm phase II study of everolimus in patients with SEGA n=28.
for 26 weeks and most patients enrolled into a long-term, open-label extension study.